JP3816999B2 - Bioactive glass-containing oral coating - Google Patents
Bioactive glass-containing oral coating Download PDFInfo
- Publication number
- JP3816999B2 JP3816999B2 JP32387196A JP32387196A JP3816999B2 JP 3816999 B2 JP3816999 B2 JP 3816999B2 JP 32387196 A JP32387196 A JP 32387196A JP 32387196 A JP32387196 A JP 32387196A JP 3816999 B2 JP3816999 B2 JP 3816999B2
- Authority
- JP
- Japan
- Prior art keywords
- bioactive glass
- weight
- oral
- glass
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000005313 bioactive glass Substances 0.000 title claims description 33
- 239000011248 coating agent Substances 0.000 title claims description 25
- 238000000576 coating method Methods 0.000 title description 11
- -1 B 2 O 3 Inorganic materials 0.000 claims description 33
- 238000002156 mixing Methods 0.000 claims description 14
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 208000002925 dental caries Diseases 0.000 claims description 5
- 229910010272 inorganic material Inorganic materials 0.000 claims description 5
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 5
- 150000002484 inorganic compounds Chemical class 0.000 claims description 4
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims description 3
- 229910018068 Li 2 O Inorganic materials 0.000 claims description 3
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 3
- 230000007547 defect Effects 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 210000000214 mouth Anatomy 0.000 claims description 2
- 239000011521 glass Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 229930195729 fatty acid Natural products 0.000 description 16
- 239000010408 film Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 9
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052586 apatite Inorganic materials 0.000 description 5
- 230000000975 bioactive effect Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000002966 varnish Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000000025 natural resin Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 238000004017 vitrification Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 229910052882 wollastonite Inorganic materials 0.000 description 2
- 239000010456 wollastonite Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- NMGPHUOPSWFUEB-UHFFFAOYSA-N 2-(butylamino)ethyl 2-methylprop-2-enoate Chemical compound CCCCNCCOC(=O)C(C)=C NMGPHUOPSWFUEB-UHFFFAOYSA-N 0.000 description 1
- ZKYCLDTVJCJYIB-UHFFFAOYSA-N 2-methylidenedecanamide Chemical compound CCCCCCCCC(=C)C(N)=O ZKYCLDTVJCJYIB-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000000120 Artificial Saliva Substances 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- GEIAQOFPUVMAGM-UHFFFAOYSA-N ZrO Inorganic materials [Zr]=O GEIAQOFPUVMAGM-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- LZBIYPIDWSGLOV-UHFFFAOYSA-N dimethyl(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC=C LZBIYPIDWSGLOV-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- FYUWIEKAVLOHSE-UHFFFAOYSA-N ethenyl acetate;1-ethenylpyrrolidin-2-one Chemical compound CC(=O)OC=C.C=CN1CCCC1=O FYUWIEKAVLOHSE-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000013212 metal-organic material Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- AXCXHFKZHDEKTP-UHFFFAOYSA-N para-methoxycinnamaldehyde Natural products COC1=CC=C(C=CC=O)C=C1 AXCXHFKZHDEKTP-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 208000008655 root caries Diseases 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は、歯牙表面にハイドロキシアパタイト膜を形成する口腔用塗布剤に関する。
【0002】
【従来の技術】
ガラス、セラミックスの中には生体組織と自然に結合するものがあり、これらは生体活性材料と称される。生体活性能をもつ生体活性ガラスもその一種であり、すでに人工骨や人工歯根として用いられている。
これらの生体活性ガラスは、そのガラス中にアパタイトやウォラストナイトなどの結晶を含む生体活性結晶化ガラスと、そのような結晶を含まない通常の生体活性ガラスとに大別できる。例えば、特公昭62−10939号公報には、アパタイトおよびウォラストナイト結晶を含む人工骨用結晶化ガラスとその製造法が開示されており、その結晶化ガラスが生体親和性に優れ、骨と直接化学結合を形成し、機械的強度にも優れることが記載されている。
また、特開平6−30984号公報には、CaOとSiO2を主成分とするガラスまたは結晶化ガラスからなる人工骨において、ガラス表面に疎水基を結合させてCa2+イオンの溶出量を調節することにより、ガラスの強度劣化を防止する技術が開示されている。
特開平5−31166号公報には、チタンなどの金属に生体活性ガラスをコーティングし、骨補填材として用いる技術が開示されている。
さらに、特開平2−255515号公報には、生体活性ガラスを用いて、無機材料、金属材料、有機材料を問わず、骨修復材料、体内埋め込み式医療器具器材、医療用品、人工臓器など、生体中で使われる全ての材料の表面に、生体内の骨と類似の生体活性アパタイト膜を形成させる方法が開示されている。
一方、口腔剤分野においては、被膜形成剤は公知であり、シリコン誘導体を用いて、被膜を形成し、ステインやう蝕を抑制する技術(特開平2−209805号公報)、フルオロアルキルリン酸エステルを用いて、歯面をコーティングし、プラークやステインを抑制する技術(特開平3−38517号公報)、高級アルキルベタインを用いて歯面に薄膜を形成し、プラーク形成を阻害する技術(特開平4−134025号公報)などが開示されている。また、天然樹脂とエタノールからなるバーニッシュ基剤に抗菌剤を配合し、長期活性を有する抗菌製剤に関する技術(特表平5−508383号公報)、徐放性アクリル系重合体、薬剤、放出調整剤からなり、薬剤の徐放性を与えるポリマー製剤に関する技術(特開平3−128316号公報)、キレート性のカップリング剤を揮発性溶剤に溶解した歯科用プライマーワニスが、歯面と良好な接着力を与える技術(特開昭50−100892号公報)などが開示されている。しかし、生体活性ガラスを歯面に滞留させ、歯牙表面でハイドロキシアパタイトを形成させる技術についての開示はない。
【0003】
【発明が解決しようとする課題】
本発明は、歯面に生体活性ガラスを滞留させ、歯牙表面でのハイドロキシアパタイトの形成を図ることを目的とする。
【0004】
【課題を解決するための手段】
本発明者は、上記の問題点を解決すべく鋭意検討した結果、生体活性ガラスと被膜形成物質と有機溶剤を配合することにより、歯牙表面に長期に生体活性ガラスを滞留させ、均一なハイドロキシアパタイト膜が形成できることを見出し、本発明を完成するに至った。
すなわち、本発明は、生体活性ガラスと、被膜形成剤と、有機溶剤とを配合してなる口腔用塗布剤を提供するものである。
本発明によれば、生体活性ガラスを歯牙表面に滞留させることができ、歯牙表面でのハイドロキシアパタイトの効果的な形成が図れ、う蝕の予防にすぐれた効果が発揮される。
【0005】
【発明の実施の形態】
本発明に用いる生体活性ガラスは、歯牙表面と自然に結合するガラス材料であれば限定されるものではなく、そのガラス中に結晶を含有する生体活性結晶化ガラス、あるいはそのような結晶を含有しない通常の生体活性ガラスのいずれであってもよい。生体活性ガラスの組成は、ガラス全体に対してSiO2を20〜70重量%、CaOを10〜60重量%含有するのが好ましく、特に、SiO2を30〜60重量%、CaOを10〜50重量%およびNa2Oを0〜30重量%含有するのが好ましい。ガラス中のSiO2が20重量%に満たないと歯牙表面との親和性が低下し、一方、70重量%を超えるとガラス化が困難となるため好ましくない。また、ガラス中のCaOが10重量%に満たないと歯牙表面との親和性が低下し、一方、50重量%を超えるとガラス化が困難となるため好ましくない。Na2Oはガラスを低融性とするが、30重量%を超えると歯牙表面との親和性が低下するため好ましくない。
また、本発明に用いる生体活性ガラスには、P2O5、K2O、Li2O、TiO2、Al2O3、MgO、B2O3、ZrO2およびFよりなる群から選択される1種または2種以上の無機化合物を含有させることができる。これらの無機化合物のうち、P2O5はガラスを安定化し、K2O、Li2OおよびB2O3はガラスを低融性とし、TiO2、Al2O3、MgO、ZrO2およびFはアパタイトのコーティング速度を調節するよう作用する。これらの無機化合物は、生体活性ガラス全体に対して0〜30重量%を含有させることができる。
本発明の塗布剤においては、これら生体活性ガラスの1種または2種以上を組み合わせて、塗布剤全量に対して0.001〜10重量%配合することができる。配合量が0.001重量%に満たないと歯牙表面にアパタイトが形成されず、一方、10重量%を超えて配合しても、それ以上の効果は期待できない。
本発明に用いる生体活性ガラスは、球状、ビーズ状、粒状、顆粒状などの形状を有しており、例えば、特開昭60−239341号公報などに開示される方法に基づいて製造できる。また、生体活性ガラスは、32メッシュパス未満のものが好適に用いられ、65メッシュパスが特に好ましい。大きさが32メッシュ以上となると塗布剤の使用感が損なわれるため好ましくない。
【0006】
本発明に用いる皮膜形成物質は、皮膜形成用に公知のものが使用でき、例えば、シェラック樹脂、ロジン、サンダラック、アルキッド樹脂、コパライト、スマトラ安息樹脂等の天然樹脂、ポリビニルアルコール、ポリビニルピロリドン、ポリウレタン、ポリスチレン、ポリメチルメタクリレート、ポリ酢酸ビニル、ポリ塩化ビニル、ポリアクリロニトリル、ビニルピロリドン/酢酸ビニルポリマー、ビニルピロリドン/ジメチルアミノエチルメタクリレートコポリマー等のノニオン性高分子、カルボキシビニルポリマー、メチルビニルエーテル/マレイン酸エステルコポリマー、アクリル酸エステル/メタアクリル酸エステルコポリマー、酢酸ビニル/クロトン酸コポリマー等のアニオン性高分子、ジメチルアリルアンモニウムクロライドポリマー、ヒドロキシエチルセルロース/ジメチルアリルアンモニウムクロライドコポリマー、ビニルピロリドン4級化ジアルキルアミノアルキルアクリレートポリマー等のカチオン性ポリマー、高級アルキルベタイン、ジアルキルアミノエチルメタクリレート重合物のモノクロル酢酸両性化物、オクチルアクリルアミド/ブチルアミノエチルメタクリレート/アクリル酸エステルコポリマー等の両性高分子、フルオロアルキルリン酸エステル等のフッ素樹脂、ジメチルシロキサン等のシリコン誘導体等であり、有機溶剤に溶解または分散するものである。
これらの皮膜形成物質は、1種あるいは2種以上を併用してもよく、その配合量は、塗布剤全量に対して0.01〜15重量%である。配合量が0.01重量%より少ないと、皮膜形成能が乏しく、配合量が15重量%を超えると生体活性ガラスの活性能が損なわれるので好ましくない。
【0007】
本発明に用いる有機溶剤は、例えば、酢酸エチル、ジクロロメタン、クロロホルム、アルコール、ジオキサン、シロキサン、ヘキサン、シクロヘキサン、ヘキサン、アセトン、エーテル、石油エーテル、炭酸プロピレン等の揮発性有機溶剤であり、これらも単独で、あるいは2種以上を組み合わせてよく、その配合量は塗布剤全量に対して10〜90重量%、好ましくは20〜70重量%である。
【0008】
本発明の口腔用塗布剤は、常法により、エアゾール、ミスト、フォーム、バーニッシュなどの形態とすることができ、直接歯面に吹き付ける方法や、トレーを用いる方法、あるいはハケで塗布する方法等により歯面に適用される。
本発明の口腔用塗布剤には、上記の必須成分以外に、界面活性剤、香味剤、甘味剤、pH調整剤、湿潤剤などの基材、さらに薬効成分などを、適宜、発明の効果を損なわない範囲で配合できる。
【0009】
界面活性剤としては、非イオン性界面活性剤、アニオン性界面活性剤、両性界面活性剤が挙げられ、非イオン性界面活性剤は、例えば、ショ糖脂肪酸エステル、マルトース脂肪酸エステル、マルチトール脂肪酸エステル、マルトトリイトール脂肪酸エステル、マルトテトライトール脂肪酸エステル、マルトペンタイトール脂肪酸エステル、マルトヘキサイトール脂肪酸エステル、マルトヘプタイトール脂肪酸エステル、ソルビタン脂肪酸エステル、ラクトース脂肪酸エステル、ラクチノース脂肪酸エステル、ポリオキシエチレンポリオキシプロピレングリコールエーテル、ポリオキシエチレンソルビタンモノラウレート、ポリオキシエチレンソルビタンモノステアレートなどのポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレン脂肪酸エステル、脂肪酸モノグリセライド、ポリオキシエチレン高級アルコールエーテル、ポリオキシエチレンポリオキシプロピレン脂肪酸エステルなどが挙げられる。
また、アニオン性界面活性剤としては、例えば、ラウリル硫酸ナトリウム、ミリスチル硫酸ナトリウムなどのアルキル基の炭素数が8〜18である高級アルキル硫酸エステルの水溶性塩、ポリオキシエチレンアルキル硫酸塩、アルキルスルホ酢酸塩、α−オレフィンスルホン酸塩、アルキルスルホコハク酸誘導体、高級脂肪酸ナトリウムモノグリセライドモノサルフェート、N−メチル−N−パルミトイルタウライド塩、N−長鎖アシル塩基性アミノ酸塩などが挙げられる。
両性界面活性剤としては、ベタイン型、イミダゾリウム型、イミダゾリウムベタイン型、アミノ酸型、アミンオキシド型などのカルボン酸型などがあげられる。
これら界面活性剤は、単独で用いても2種以上を併用してもよく、その配合量は、通常、塗布剤全量に対して0.001〜5重量%である。
【0010】
香味剤としては、例えば、メントール、カルボン、アネトール、オイゲノール、サリチル酸メチル、リモネン、オシメン、n−デシルアルコール、シトロネロール、α−テルピネオール、メチルアセテート、シトロネリルアセテート、メチルオイゲノール、シネオール、リナロール、エチルリナロール、ワニリン、チモール、スペアミント油、ペパーミント油、レモン油、オレンジ油、セージ油、ローズマリー油、桂皮油、ピメント油、珪藻油、シソ油、冬緑油、丁子油、ユーカリ油などが挙げられ、通常、これらの1種以上を、塗布剤全量に対して0.1〜3重量%である。
甘味剤としては、サッカリンナトリウム、アセチルファームカリウム、ステビオサイド、ネオヘスポリジルジヒドロカルコン、グリチルリチン、ペリラルチン、タウマチン、アスパラチルフェニルアラニンメチルエステル、p−メトキシシンナミックアルデヒド、キシリット、マルチット、ラクチットなどが例示できる。
また、pH調整剤としてはクエン酸、リン酸、リンゴ酸、ピロリン酸、乳酸、酒石酸、グリセロリン酸、酢酸、硝酸、またはこれらの化学的に可能な塩や水酸化ナトリウムなどが挙げられる。
また、ソルビット、グリセリン、エチレングリコール、プロピレングリコール、1,3ーブチレングリコール、ポリエチレングリコール、ポリプロピレングリコールなどの湿潤剤を、単独で用いても2種以上併用してもよい。
また、グルコン酸クロルヘキシジン、塩化セチルピリジニウム、トリクロサンなどの殺菌剤、デキストラナーゼ、アミラーゼ、プロテアーゼ、ムタナーゼ、リゾチーム、溶菌酵素(リテックエンザイム)などの酵素、モノフルオロリン酸ナトリウム、モノフルオロリン酸カリウムなどのアルカリ金属モノフルオロホスフェート、フッ化ナトリウム、フッ化第一スズなどのフッ化物、ビタミン誘導体、トラネキサム酸およびイプシロンアミノカプロン酸、アルミニウムクロルヒドロキシルアラントイン、ジヒドロコレステロール、グリチルリチン塩類、グリチルレチン酸、グリセロホスフェート、クロロフィル、塩化ナトリウム、カロペプタイド、水溶性無機リン酸化合物などの薬効成分も配合できる。
【0011】
【実施例】
つぎに、実施例および比較例を挙げ、本発明をさらに具体的に説明するが、本発明はこれら実施例に限定されるものではない。特に断らない限り「%」は重量%を示す。
実施例1
成 分 配合量(%)
エタノール 30.0
グリセリン 10.0
ポリオキシエチレン硬化ヒマシ油 1.0
アクリル酸系コポリマー 1.0
生体活性ガラス 10.0
(SiO2/CaO:50/50)
水 48.0
合計 100.0
これらの成分を常法により混合し、口腔用塗布剤を製造した。
【0012】
比較例1
成 分 配合量(%)
エタノール 30.0
グリセリン 10.0
ポリオキシエチレン硬化ヒマシ油 1.0
生体活性ガラス 10.0
(SiO2/CaO:50/50)
水 49.0
合計 100.0
これらの成分を常法により混合し、口腔用塗布剤を製造した。
実施例1および比較例1を、それぞれ0.1gづつアクリル板に塗布し、人工唾液中に24時間浸漬した。24時間後、実施例1の被膜にはハイドロキシアパタイトが形成されていることが誘導結晶プラズマ発光分析で確認できた。
【0013】
実施例2
成 分 配合量(%)
エタノール 50.0
サンダラック 2.0
生体活性ガラス 10.0
(SiO2/CaO/Na2O:50:25:25)
水 38.0
合計 100.0
これらの成分を常法により混合し、口腔用塗布剤を製造した。
【0014】
比較例2
成 分 配合量(%)
エタノール 50.0
生体活性ガラス 10.0
(SiO2/CaO/Na2O:50:25:25)
水 40.0
合計 100.0
これらの成分を常法により混合し、口腔用塗布剤を製造した。
【0015】
実施例3
成 分 配合量(%)
酢酸エチル 85.0
ポリウレタン 5.0
生体活性ガラス 10.0
(SiO2/CaO/Na2O/P2O5:45:25:25:5)
合計 100.0
これらの成分を常法により混合し、口腔用塗布剤を製造した。
【0016】
実施例2および実施例3の塗布剤を抜歯した成人永久歯エナメルにハケで塗布した。この成人永久歯を全唾液中に1週間浸漬した。実施例2および3では、1週間後も成人永久歯上に被膜は形成されており、被膜から抽出した化合物からはハイドロキシアパタイトが検出された。一方、比較例2を同様に成人永久歯に塗布し、全唾液に浸漬したところ、1週間後には被膜は残存していなかった。
これらの結果より、本発明の口腔用組成物は、歯面に被膜を形成し、かつ均一に歯牙表面にハイドロキシアパタイト膜を形成することが確認された。
【0017】
【発明の効果】
本発明によれば、歯牙表面に均一なハイドロキシアパタイト膜が形成でき、2次う蝕、根面う蝕、くさび状欠損などの欠損の修復、知覚過敏の緩和、歯牙表面の審美的なコーティングに有効な口腔用塗布剤を提供することができる。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to an oral coating agent for forming a hydroxyapatite film on a tooth surface.
[0002]
[Prior art]
Some glass and ceramics naturally bond with biological tissues, and these are called bioactive materials. Bioactive glass having bioactive ability is one type, and has already been used as an artificial bone or an artificial tooth root.
These bioactive glasses can be broadly classified into bioactive crystallized glass containing crystals such as apatite and wollastonite in the glass and ordinary bioactive glasses not containing such crystals. For example, Japanese Examined Patent Publication No. 62-10939 discloses a crystallized glass for artificial bone containing apatite and wollastonite crystals and a method for producing the same. The crystallized glass is excellent in biocompatibility and directly with bone. It describes that it forms a chemical bond and is excellent in mechanical strength.
In JP-A-6-30984, an artificial bone made of glass or crystallized glass mainly composed of CaO and SiO 2 is used to adjust the elution amount of Ca 2+ ions by binding hydrophobic groups to the glass surface. Thus, a technique for preventing the strength deterioration of the glass is disclosed.
Japanese Patent Application Laid-Open No. 5-31166 discloses a technique in which a metal such as titanium is coated with bioactive glass and used as a bone grafting material.
Furthermore, in Japanese Patent Laid-Open No. 2-255515, bioactive glass is used for living body such as bone repair material, implantable medical device, medical supplies, artificial organ, regardless of inorganic material, metal material, and organic material. A method for forming a bioactive apatite film similar to bone in vivo on the surface of all materials used therein is disclosed.
On the other hand, in the field of oral preparations, film forming agents are known, and a technique for forming a film using a silicon derivative to suppress stains and caries (Japanese Patent Laid-Open No. Hei 2-209805), fluoroalkyl phosphate ester A technique for coating the tooth surface and suppressing plaque and stain (Japanese Patent Laid-Open No. 3-38517), and a technique for forming a thin film on the tooth surface using higher alkyl betaine to inhibit plaque formation (Japanese Patent Laid-open No. Hei 4). -134025) and the like. In addition, antibacterial agents are blended into a varnish base consisting of natural resin and ethanol, and technologies related to antibacterial preparations with long-term activity (Japanese Patent Publication No. 5-508383), sustained-release acrylic polymers, drugs, release control Technology for polymer preparations that provide a sustained release of drugs (Japanese Patent Laid-Open No. 3-128316), dental primer varnish in which a chelating coupling agent is dissolved in a volatile solvent has good adhesion to the tooth surface A technique for applying force (Japanese Patent Laid-Open No. 50-100952) is disclosed. However, there is no disclosure of a technique for retaining bioactive glass on the tooth surface and forming hydroxyapatite on the tooth surface.
[0003]
[Problems to be solved by the invention]
An object of the present invention is to make bioactive glass stay on the tooth surface and form hydroxyapatite on the tooth surface.
[0004]
[Means for Solving the Problems]
As a result of intensive studies to solve the above problems, the present inventor has made bioactive glass stay on the tooth surface for a long time by blending bioactive glass, a film-forming substance, and an organic solvent, and uniform hydroxyapatite. The inventors have found that a film can be formed and have completed the present invention.
That is, the present invention provides an oral coating composition comprising a bioactive glass, a film-forming agent, and an organic solvent.
According to the present invention, bioactive glass can be retained on the tooth surface, hydroxyapatite can be effectively formed on the tooth surface, and an excellent effect in preventing caries can be exhibited.
[0005]
DETAILED DESCRIPTION OF THE INVENTION
The bioactive glass used in the present invention is not limited as long as it is a glass material that naturally binds to the tooth surface, and bioactive crystallized glass containing crystals in the glass, or does not contain such crystals. Any of normal bioactive glass may be used. The composition of the bioactive glass is preferably 20 to 70% by weight of SiO 2 and 10 to 60% by weight of CaO with respect to the whole glass, particularly 30 to 60% by weight of SiO 2 and 10 to 50% of CaO. It is preferable to contain 0 to 30% by weight of Na 2 O. If the SiO 2 content in the glass is less than 20% by weight, the affinity with the tooth surface is lowered. On the other hand, if it exceeds 70% by weight, vitrification becomes difficult. On the other hand, if the CaO content in the glass is less than 10% by weight, the affinity with the tooth surface is lowered. On the other hand, if it exceeds 50% by weight, vitrification becomes difficult. Na 2 O is a TeiTorusei the glass, but not preferred to lower the affinity exceeds the tooth surface 30 wt%.
The bioactive glass used in the present invention is selected from the group consisting of P 2 O 5 , K 2 O, Li 2 O, TiO 2 , Al 2 O 3 , MgO, B 2 O 3 , ZrO 2 and F. 1 type, or 2 or more types of inorganic compounds can be contained. Of these inorganic compounds, P 2 O 5 stabilizes the glass, K 2 O, Li 2 O, and B 2 O 3 render the glass low fusible, TiO 2 , Al 2 O 3 , MgO, ZrO 2 and F acts to adjust the coating speed of the apatite. These inorganic compounds can be contained in an amount of 0 to 30% by weight based on the entire bioactive glass.
In the coating agent of this invention, 0.001-10 weight% can be mix | blended with respect to the coating agent whole quantity combining 1 type, or 2 or more types of these bioactive glass. If the blending amount is less than 0.001% by weight, no apatite is formed on the tooth surface. On the other hand, if the blending amount exceeds 10% by weight, no further effect can be expected.
The bioactive glass used in the present invention has a spherical shape, a bead shape, a granular shape, a granular shape, or the like, and can be manufactured based on, for example, a method disclosed in JP-A-60-239341. In addition, as the bioactive glass, glass having a mesh size of less than 32 mesh is preferably used, and 65 mesh pass is particularly preferable. When the size is 32 mesh or more, the feeling of use of the coating agent is impaired, which is not preferable.
[0006]
As the film-forming substance used in the present invention, known substances for film formation can be used, for example, natural resins such as shellac resin, rosin, sandalac, alkyd resin, copalite, and sumatra benzoic resin, polyvinyl alcohol, polyvinyl pyrrolidone, polyurethane , Nonionic polymers such as polystyrene, polymethyl methacrylate, polyvinyl acetate, polyvinyl chloride, polyacrylonitrile, vinyl pyrrolidone / vinyl acetate polymer, vinyl pyrrolidone / dimethylaminoethyl methacrylate copolymer, carboxy vinyl polymer, methyl vinyl ether / maleic ester Copolymer, anionic polymer such as acrylate / methacrylate copolymer, vinyl acetate / crotonic acid copolymer, dimethylallyl ammonium chloride , Hydroxyethylcellulose / dimethylallylammonium chloride copolymer, cationic polymer such as vinylpyrrolidone quaternized dialkylaminoalkyl acrylate polymer, higher alkylbetaine, monochloroacetic acid amphoteric product of dialkylaminoethyl methacrylate polymer, octylacrylamide / butylaminoethyl methacrylate / Amphoteric polymers such as acrylic acid ester copolymers, fluororesins such as fluoroalkyl phosphates, silicon derivatives such as dimethylsiloxane, etc., which are dissolved or dispersed in organic solvents.
These film-forming substances may be used alone or in combination of two or more, and the blending amount is 0.01 to 15% by weight with respect to the total amount of the coating agent. When the blending amount is less than 0.01% by weight, the film forming ability is poor, and when the blending amount exceeds 15% by weight, the activity ability of the bioactive glass is impaired, which is not preferable.
[0007]
Examples of the organic solvent used in the present invention are volatile organic solvents such as ethyl acetate, dichloromethane, chloroform, alcohol, dioxane, siloxane, hexane, cyclohexane, hexane, acetone, ether, petroleum ether, and propylene carbonate, and these are also used alone. Alternatively, two or more kinds may be combined, and the blending amount is 10 to 90% by weight, preferably 20 to 70% by weight, based on the total amount of the coating agent.
[0008]
The oral coating of the present invention can be in the form of aerosol, mist, foam, varnish, etc. by a conventional method, such as a method of spraying directly on the tooth surface, a method of using a tray, or a method of applying with a brush, etc. Is applied to the tooth surface.
In addition to the above essential components, the oral coating agent of the present invention includes base materials such as surfactants, flavoring agents, sweeteners, pH adjusters, wetting agents, and other medicinal components as appropriate. It can mix | blend in the range which is not impaired.
[0009]
Examples of the surfactant include a nonionic surfactant, an anionic surfactant, and an amphoteric surfactant. Examples of the nonionic surfactant include sucrose fatty acid ester, maltose fatty acid ester, and maltitol fatty acid ester. , Maltotriitol fatty acid ester, maltotetritole fatty acid ester, maltopentylitol fatty acid ester, maltohexaitol fatty acid ester, maltoheptytitol fatty acid ester, sorbitan fatty acid ester, lactose fatty acid ester, lactinose fatty acid ester, polyoxyethylene Polyoxyethylene sorbitan fatty acid esters such as polyoxypropylene glycol ether, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monostearate, polyoxyethylene Emissions hardened castor oil, polyoxyethylene fatty acid esters, fatty acid monoglyceride, polyoxyethylene higher alcohol ethers, polyoxyethylene polyoxypropylene fatty acid esters.
Examples of the anionic surfactant include water-soluble salts of higher alkyl sulfates having 8 to 18 carbon atoms in the alkyl group, such as sodium lauryl sulfate and sodium myristyl sulfate, polyoxyethylene alkyl sulfate, alkyl sulfo Examples include acetates, α-olefin sulfonates, alkylsulfosuccinic acid derivatives, higher fatty acid sodium monoglyceride monosulfates, N-methyl-N-palmitoyl tauride salts, N-long chain acyl basic amino acid salts, and the like.
Examples of the amphoteric surfactant include betaine type, imidazolium type, imidazolium betaine type, amino acid type, carboxylic acid type such as amine oxide type, and the like.
These surfactants may be used alone or in combination of two or more thereof, and the amount thereof is usually 0.001 to 5% by weight based on the total amount of the coating agent.
[0010]
As a flavoring agent, for example, menthol, carvone, anethole, eugenol, methyl salicylate, limonene, ocimene, n-decyl alcohol, citronellol, α-terpineol, methyl acetate, citronellyl acetate, methyl eugenol, cineol, linalool, ethyl linalool, Examples include crocodile, thymol, spearmint oil, peppermint oil, lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil, pimento oil, diatom oil, perilla oil, winter green oil, clove oil, eucalyptus oil, etc. These 1 or more types are 0.1 to 3 weight% with respect to the coating agent whole quantity.
Examples of the sweetening agent include saccharin sodium, acetyl farm potassium, stevioside, neohespolydyl dihydrochalcone, glycyrrhizin, perilartine, thaumatin, asparatylphenylalanine methyl ester, p-methoxycinnamic aldehyde, xylit, malt, lactit and the like.
Examples of the pH adjuster include citric acid, phosphoric acid, malic acid, pyrophosphoric acid, lactic acid, tartaric acid, glycerophosphoric acid, acetic acid, nitric acid, or chemically possible salts thereof, sodium hydroxide, and the like.
In addition, wetting agents such as sorbit, glycerin, ethylene glycol, propylene glycol, 1,3-butylene glycol, polyethylene glycol, and polypropylene glycol may be used alone or in combination of two or more.
Also, bactericides such as chlorhexidine gluconate, cetylpyridinium chloride, triclosan, enzymes such as dextranase, amylase, protease, mutanase, lysozyme, lytic enzyme (lytechenzyme), sodium monofluorophosphate, potassium monofluorophosphate, etc. Alkali metal monofluorophosphate, fluorides such as sodium fluoride, stannous fluoride, vitamin derivatives, tranexamic acid and epsilon aminocaproic acid, aluminum chlorohydroxyl allantoin, dihydrocholesterol, glycyrrhizin salts, glycyrrhetinic acid, glycerophosphate, chlorophyll, Medicinal ingredients such as sodium chloride, caropeptide and water-soluble inorganic phosphate compounds can also be blended.
[0011]
【Example】
EXAMPLES Next, the present invention will be described more specifically with reference to examples and comparative examples, but the present invention is not limited to these examples. Unless otherwise specified, “%” indicates wt%.
Example 1
Component Blending amount (%)
Ethanol 30.0
Glycerin 10.0
Polyoxyethylene hydrogenated castor oil 1.0
Acrylic acid copolymer 1.0
Bioactive glass 10.0
(SiO 2 / CaO: 50/50)
Water 48.0
Total 100.0
These components were mixed by a conventional method to produce an oral coating.
[0012]
Comparative Example 1
Component Blending amount (%)
Ethanol 30.0
Glycerin 10.0
Polyoxyethylene hydrogenated castor oil 1.0
Bioactive glass 10.0
(SiO 2 / CaO: 50/50)
Water 49.0
Total 100.0
These components were mixed by a conventional method to produce an oral coating.
Example 1 and Comparative Example 1 were each applied to an acrylic plate in an amount of 0.1 g, and immersed in artificial saliva for 24 hours. After 24 hours, it was confirmed by induction crystal plasma emission analysis that hydroxyapatite was formed on the coating of Example 1.
[0013]
Example 2
Component Blending amount (%)
Ethanol 50.0
Sandalak 2.0
Bioactive glass 10.0
(SiO 2 / CaO / Na 2 O: 50:25:25)
Water 38.0
Total 100.0
These components were mixed by a conventional method to produce an oral coating.
[0014]
Comparative Example 2
Component Blending amount (%)
Ethanol 50.0
Bioactive glass 10.0
(SiO 2 / CaO / Na 2 O: 50:25:25)
Water 40.0
Total 100.0
These components were mixed by a conventional method to produce an oral coating.
[0015]
Example 3
Component Blending amount (%)
Ethyl acetate 85.0
Polyurethane 5.0
Bioactive glass 10.0
(SiO 2 / CaO / Na 2 O / P 2 O 5 : 45: 25: 25: 5)
Total 100.0
These components were mixed by a conventional method to produce an oral coating.
[0016]
It applied to the adult permanent tooth enamel which extracted the coating agent of Example 2 and Example 3 with a brush. This adult permanent tooth was immersed in whole saliva for 1 week. In Examples 2 and 3, a film was formed on the adult permanent tooth after 1 week, and hydroxyapatite was detected from the compound extracted from the film. On the other hand, when Comparative Example 2 was similarly applied to adult permanent teeth and immersed in whole saliva, no film remained after one week.
From these results, it was confirmed that the composition for oral cavity of the present invention forms a film on the tooth surface and uniformly forms a hydroxyapatite film on the tooth surface.
[0017]
【The invention's effect】
According to the present invention, a uniform hydroxyapatite film can be formed on the tooth surface, repairing defects such as secondary caries, root caries and wedge-shaped defects, reducing hypersensitivity, and aesthetic coating on the tooth surface. An effective oral application agent can be provided.
Claims (8)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32387196A JP3816999B2 (en) | 1996-12-04 | 1996-12-04 | Bioactive glass-containing oral coating |
PCT/JP1997/003843 WO1998017236A1 (en) | 1996-10-23 | 1997-10-23 | Oral preparations containing biologically active crystallized glass |
AU47232/97A AU4723297A (en) | 1996-10-23 | 1997-10-23 | Oral preparations containing biologically active crystallized glass |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32387196A JP3816999B2 (en) | 1996-12-04 | 1996-12-04 | Bioactive glass-containing oral coating |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10167942A JPH10167942A (en) | 1998-06-23 |
JP3816999B2 true JP3816999B2 (en) | 2006-08-30 |
Family
ID=18159533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP32387196A Expired - Fee Related JP3816999B2 (en) | 1996-10-23 | 1996-12-04 | Bioactive glass-containing oral coating |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3816999B2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1272144A4 (en) * | 2000-03-27 | 2006-04-26 | Schott Ag | NEW COSMETIC BODY CLEANING AGENT AND FOOD SUPPLEMENTS CONTAINING BIOACTIVE GLASS AND METHODS FOR THE PREPARATION AND USE THEREOF |
EP2832342A3 (en) | 2004-11-16 | 2015-02-11 | 3M Innovative Properties Company of 3M Center | Dental compositions with calcium phosphorus releasing glass |
AU2005306869B2 (en) | 2004-11-16 | 2011-11-10 | 3M Innovative Properties Company | Dental fillers including a phosphoruscontaining surface treatment |
KR101277869B1 (en) | 2004-11-16 | 2013-07-30 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | Dental fillers and compositions including phosphate salts |
BRPI0914713A2 (en) * | 2008-06-27 | 2017-05-23 | Novamin Tech Inc | oral care composition |
US20100086497A1 (en) * | 2008-10-08 | 2010-04-08 | Biofilm Limited | Tooth remineralisation |
TWI469795B (en) | 2009-04-01 | 2015-01-21 | Colgate Palmolive Co | Dual action dentifrice compositions to prevent hypersensitivity and promote remineralization |
TWI391148B (en) | 2009-04-01 | 2013-04-01 | Colgate Palmolive Co | Non-aqueous dentifrice composition with bioacceptable and bioactive glass and methods of use and manufacture thereof |
AR076180A1 (en) * | 2009-04-01 | 2011-05-26 | Colgate Palmolive Co | COMPOSITIONS OF ORAL USE FOR THE TREATMENT OF DENTAL SENSITIVITY AND METHODS FOR ITS PRODUCTION AND USE |
EP2432444B1 (en) * | 2009-05-18 | 2017-08-23 | Colgate-Palmolive Company | Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof |
JP5653550B1 (en) * | 2014-05-30 | 2015-01-14 | 株式会社松風 | Neutralization promoting ion sustained release dental film |
KR20240015412A (en) * | 2022-07-27 | 2024-02-05 | (주)메디클러스 | Oral composition |
EP4393468A1 (en) * | 2022-12-28 | 2024-07-03 | Septodont ou Septodont SAS ou Specialites Septodont | Dental anhydrous varnish composition |
-
1996
- 1996-12-04 JP JP32387196A patent/JP3816999B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH10167942A (en) | 1998-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2019410C (en) | Liquid polymer composition, and method of use | |
US4883534A (en) | Benzoin antimicrobial dental varnishes | |
US5639795A (en) | Liquid polymer composition, and method of use | |
JP5816549B2 (en) | Compositions and methods for improving fluoride uptake using bioactive glass | |
JP3816999B2 (en) | Bioactive glass-containing oral coating | |
MX2011003836A (en) | Tooth remineralisation. | |
JP2007515427A (en) | Compositions and methods for preventing or reducing plaque and / or gingivitis using a bioactive glass-containing dentifrice | |
JP2002187809A (en) | Tooth coating agent | |
US20200038300A1 (en) | Oral care formulation system providing amorphous calcium phosphate | |
JP2005187330A (en) | Product for application to tooth and method for selecting gel composition | |
JPH1017449A (en) | Composition for hyperesthesia | |
JP3022039B2 (en) | Oral composition for preventing tooth coloring | |
JP3623086B2 (en) | Bioactive glass-containing oral composition | |
KR20190038040A (en) | Fluoride varnish composition for enhanced penetration of dentinal tubules and and keep of coating effect and processes for the preparation thereof | |
CA2284791C (en) | Method of remineralizing teeth | |
WO1998017236A1 (en) | Oral preparations containing biologically active crystallized glass | |
JP4539832B2 (en) | Dentifrice composition | |
JPH10182393A (en) | Oral composition containing crystallized glass for living body activation | |
JP2001302428A (en) | Tooth coating composition | |
JPH0692860A (en) | Therapeutic agent for hypersthesia | |
JPH10120540A (en) | Composition containing biologically active glass for oral cavity | |
JP2001247438A (en) | Bleaching composition for tooth and bleaching set | |
JPH10139644A (en) | Oral cavity composition containing bioactive glass | |
JPH1112144A (en) | Liquid oral composition | |
CN112334197B (en) | Dentifrices containing carboxylic acids or alkali metal salts thereof and a source of free fluoride ions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060131 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060331 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060502 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060512 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060606 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060609 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090616 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100616 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110616 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120616 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120616 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130616 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |